Galapagos is a commercial-stage biotechnology company, specialised in the discovery and development of small molecule medicines with novel modes of action. Galapagos is seeking research in rheumatoid arthritis (RA) or intestinal bowel diseases (IBD), among other autoimmune/inflammatory diseases.
Targets and Therapeutic Interventions
Technology
Academic Researcher
Centre of Excellence
Research Project
Spinout Company
Technology
Academic Researcher
Centre of Excellence
Research Project
Spinout Company
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.